Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests peer support to ease transgender surgery journey

NCT ID NCT06436560

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether virtual group support from peers who have had vaginoplasty can help transgender and non-binary people feel more prepared and less stressed before surgery. About 290 adults will be randomly assigned to either the peer support group or standard care with extra educational materials. The goal is to improve coping skills and access to surgery, and to see if this approach is acceptable to patients and staff.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 290 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identified trans or non-binary individual * Seeking vaginoplasty * Completed consultation with gender-affirming surgeon for vaginoplasty * Documented recommendation by surgeon for vaginoplasty * Can complete survey responses online, by phone or on paper. * Willing and able to participate in virtual peer support intervention * Aged 18 or older * English speaking * Able to provide independent written consent Exclusion Criteria: * Do not speak English * Cannot complete survey responses online, by phone, or on paper * Are unwilling to participate in a virtual peer support intervention * Have co-morbidities or other conditions that exclude them from candidacy for vaginoplasty * Are currently involved in delivery of the STRIVE Intervention * Are unable or unwilling to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gender affirmation surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Henry Ford Health

    Detroit, Michigan, 48202, United States

  • New York University Langone Health

    New York, New York, 10017, United States

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • Rush University

    Chicago, Illinois, 60612, United States

  • Temple University

    Philadelphia, Pennsylvania, 19140, United States

  • University of California San Francisco

    San Francisco, California, 94143, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

  • University of Washington

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.